Paola Moreno

1.2k total citations
25 papers, 1.0k citations indexed

About

Paola Moreno is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Paola Moreno has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 8 papers in Oncology. Recurrent topics in Paola Moreno's work include Neuropeptides and Animal Physiology (13 papers), Receptor Mechanisms and Signaling (8 papers) and Metabolism, Diabetes, and Cancer (7 papers). Paola Moreno is often cited by papers focused on Neuropeptides and Animal Physiology (13 papers), Receptor Mechanisms and Signaling (8 papers) and Metabolism, Diabetes, and Cancer (7 papers). Paola Moreno collaborates with scholars based in United States, Spain and Italy. Paola Moreno's co-authors include Bernardo Nuche‐Berenguer, Robert T. Jensen, María Luisa Villanueva‐Peñacarrillo, Pedro Esbrit, Terry W. Moody, Irene Ramos-Álvarez, Sonia Dapía, Samuel A. Mantey, Sergio Portal‐Núñez and Nieves González and has published in prestigious journals such as Gastroenterology, PLoS ONE and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Paola Moreno

25 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paola Moreno United States 17 591 325 296 252 149 25 1.0k
Donna Montague United States 9 637 1.1× 319 1.0× 72 0.2× 47 0.2× 213 1.4× 12 1.1k
Olugbenga A. Adebanjo United States 19 599 1.0× 232 0.7× 54 0.2× 79 0.3× 112 0.8× 28 957
Junming Luo China 15 443 0.7× 109 0.3× 111 0.4× 28 0.1× 55 0.4× 45 956
Yun Yan United States 18 379 0.6× 103 0.3× 81 0.3× 49 0.2× 19 0.1× 57 858
Jiyoon Ryu United States 15 613 1.0× 224 0.7× 61 0.2× 25 0.1× 70 0.5× 19 1.1k
Chandrasekhar Kesavan United States 14 414 0.7× 83 0.3× 148 0.5× 49 0.2× 156 1.0× 38 706
Andrea M. Norfleet United States 11 283 0.5× 86 0.3× 171 0.6× 61 0.2× 23 0.2× 12 829
Katharine E. Armour United Kingdom 8 390 0.7× 137 0.4× 61 0.2× 32 0.1× 223 1.5× 8 791
Geihan Rizkalla United States 5 137 0.2× 59 0.2× 138 0.5× 136 0.5× 36 0.2× 6 677
Miguel Pérez‐Aso United States 18 357 0.6× 83 0.3× 27 0.1× 143 0.6× 45 0.3× 23 826

Countries citing papers authored by Paola Moreno

Since Specialization
Citations

This map shows the geographic impact of Paola Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paola Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paola Moreno more than expected).

Fields of papers citing papers by Paola Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paola Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paola Moreno. The network helps show where Paola Moreno may publish in the future.

Co-authorship network of co-authors of Paola Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of Paola Moreno. A scholar is included among the top collaborators of Paola Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paola Moreno. Paola Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Moody, Terry W., Lingaku Lee, Irene Ramos-Álvarez, et al.. (2018). PAC1 regulates receptor tyrosine kinase transactivation in a reactive oxygen species-dependent manner. Peptides. 120. 170017–170017. 13 indexed citations
2.
Moreno, Paola, Samuel A. Mantey, Suk‐Hee Lee, et al.. (2018). A possible new target in lung-cancer cells: The orphan receptor, bombesin receptor subtype-3. Peptides. 101. 213–226. 27 indexed citations
3.
Moody, Terry W., Samuel A. Mantey, Paola Moreno, et al.. (2017). AM-37 and ST-36 Are Small Molecule Bombesin Receptor Antagonists. Frontiers in Endocrinology. 8. 176–176. 5 indexed citations
4.
Moreno, Paola, Irene Ramos-Álvarez, Terry W. Moody, & Robert T. Jensen. (2016). Bombesin related peptides/receptors and their promising therapeutic roles in cancer imaging, targeting and treatment. Expert Opinion on Therapeutic Targets. 20(9). 1055–1073. 93 indexed citations
5.
Nakamura, Taichi, et al.. (2016). Molecular basis for high affinity and selectivity of peptide antagonist, Bantag-1, for the orphan BB3 receptor. Biochemical Pharmacology. 115. 64–76. 10 indexed citations
6.
González, Nieves, Paola Moreno, & Robert T. Jensen. (2015). Bombesin receptor subtype 3 as a potential target for obesity and diabetes. Expert Opinion on Therapeutic Targets. 19(9). 1153–1170. 34 indexed citations
7.
Ramos-Álvarez, Irene, Taichi Nakamura, Samuel A. Mantey, et al.. (2015). Novel chiral-diazepines function as specific, selective receptor agonists with variable coupling and species variability in human, mouse and rat BRS-3 receptor cells. Peptides. 75. 8–17. 6 indexed citations
8.
Moody, Terry W., Paola Moreno, & Robert T. Jensen. (2015). Neuropeptides as lung cancer growth factors. Peptides. 72. 106–111. 19 indexed citations
9.
Moody, Terry W., Bernardo Nuche‐Berenguer, Paola Moreno, & Robert T. Jensen. (2015). CI-988 Inhibits EGFR Transactivation and Proliferation Caused by Addition of CCK/Gastrin to Lung Cancer Cells. Journal of Molecular Neuroscience. 56(3). 663–672. 13 indexed citations
10.
Moody, Terry W., Daniel C. Chan, Samuel A. Mantey, Paola Moreno, & Robert T. Jensen. (2014). SR48692 inhibits non-small cell lung cancer proliferation in an EGF receptor-dependent manner. Life Sciences. 100(1). 25–34. 26 indexed citations
11.
Moody, Terry W., Samuel A. Mantey, Paola Moreno, et al.. (2014). ML-18 is a non-peptide bombesin receptor subtype-3 antagonist which inhibits lung cancer growth. Peptides. 64. 55–61. 20 indexed citations
12.
Nuche‐Berenguer, Bernardo, Paola Moreno, & Robert T. Jensen. (2014). Elucidation of the Roles of the Src Kinases in Pancreatic Acinar Cell Signaling. Journal of Cellular Biochemistry. 116(1). 22–36. 10 indexed citations
13.
Moreno, Paola, Samuel A. Mantey, Bernardo Nuche‐Berenguer, et al.. (2013). Comparative Pharmacology of Bombesin Receptor Subtype-3, Nonpeptide Agonist MK-5046, a Universal Peptide Agonist, and Peptide Antagonist Bantag-1 for Human Bombesin Receptors. Journal of Pharmacology and Experimental Therapeutics. 347(1). 100–116. 30 indexed citations
14.
Florio, Alessia Di, Verónica Sancho, Paola Moreno, Gianfranco Delle Fave, & Robert T. Jensen. (2012). Gastrointestinal hormones stimulate growth of Foregut Neuroendocrine Tumors by transactivating the EGF receptor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1833(3). 573–582. 29 indexed citations
15.
Nuche‐Berenguer, Bernardo, Daniel Lozano, Paola Moreno, et al.. (2011). GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia. Journal of Endocrinology. 209(2). 203–210. 82 indexed citations
16.
Villanueva‐Peñacarrillo, María Luisa, Antonio Martín‐Duce, Irene Ramos-Álvarez, et al.. (2011). Characteristic of GLP-1 effects on glucose metabolism in human skeletal muscle from obese patients. Regulatory Peptides. 168(1-3). 39–44. 18 indexed citations
17.
Nuche‐Berenguer, Bernardo, Sergio Portal‐Núñez, Paola Moreno, et al.. (2010). Presence of a functional receptor for GLP‐1 in osteoblastic cells, independent of the cAMP‐linked GLP‐1 receptor. Journal of Cellular Physiology. 225(2). 585–592. 120 indexed citations
18.
Nuche‐Berenguer, Bernardo, Paola Moreno, Sergio Portal‐Núñez, et al.. (2009). Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states. Regulatory Peptides. 159(1-3). 61–66. 119 indexed citations
19.
Nuche‐Berenguer, Bernardo, Paola Moreno, Pedro Esbrit, et al.. (2009). Effect of GLP-1 Treatment on Bone Turnover in Normal, Type 2 Diabetic, and Insulin-Resistant States. Calcified Tissue International. 84(6). 453–461. 165 indexed citations
20.
Arnes, Luís, Paola Moreno, Bernardo Nuche‐Berenguer, Isabel Valverde, & María Luisa Villanueva‐Peñacarrillo. (2008). Effect of exendin-4 treatment upon glucose uptake parameters in rat liver and muscle, in normal and type 2 diabetic state. Regulatory Peptides. 153(1-3). 88–92. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Donna Montague Breakdown of academic impact, for papers by Olugbenga A. Adebanjo Breakdown of academic impact, for papers by Junming Luo Breakdown of academic impact, for papers by Yun Yan Breakdown of academic impact, for papers by Jiyoon Ryu Breakdown of academic impact, for papers by Chandrasekhar Kesavan Breakdown of academic impact, for papers by Andrea M. Norfleet Breakdown of academic impact, for papers by Katharine E. Armour Breakdown of academic impact, for papers by Geihan Rizkalla Breakdown of academic impact, for papers by Miguel Pérez‐Aso
Rankless by CCL
2026